NCT00709917View on ClinicalTrials.gov

Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

2,171

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

repaglinide

Start dose and freqency to be prescribed by the physician at his discretion following clinical practice

Trial Locations (2)

1070

Brussels

Unknown

Luxembourg

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY